Cedar Mountain Advisors’s Oncolytics Biotech ONCY Stock Holding History

Cedar Mountain Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.78K	Hold	5,651	–	–	﹤0.01%	721
2026 Q2	$5.37K	Hold	5,651	–	–	﹤0.01%	664
2026 Q1	$4.8K	Hold	5,651	–	–	﹤0.01%	669
2025 Q4	$4.94K	Hold	5,651	–	–	﹤0.01%	319
2025 Q3	$7.91K	Hold	5,651	–	–	﹤0.01%	283
2025 Q2	$4.37K	Hold	5,651	–	–	﹤0.01%	277
2025 Q1	$3.11K	Hold	5,651	–	–	﹤0.01%	274
2024 Q4	$5.16K	Hold	5,651	–	–	﹤0.01%	256
2024 Q3	$4.92K	Hold	5,651	–	–	﹤0.01%	247
2024 Q2	$5.59K	Hold	5,651	–	–	﹤0.01%	223
2024 Q1	$5.99K	Hold	5,651	–	–	﹤0.01%	214
2023 Q4	$7.63K	Hold	5,651	–	–	﹤0.01%	197
2023 Q3	$12.3K	Hold	5,651	–	–	﹤0.01%	163
2023 Q2	$14.7K	Hold	5,651	–	–	﹤0.01%	136
2023 Q1	$6.78K	Hold	5,651	–	–	﹤0.01%	189
2022 Q4	$9.21K	Hold	5,651	–	–	﹤0.01%	166
2022 Q3	$7K	Hold	5,651	–	–	﹤0.01%	186
2022 Q2	$6K	Hold	5,651	–	–	﹤0.01%	204
2022 Q1	$9K	Hold	5,651	–	–	﹤0.01%	183
2021 Q4	$8K	Hold	5,651	–	–	﹤0.01%	198
2021 Q3	$12K	Hold	5,651	–	–	﹤0.01%	151
2021 Q2	$16K	Hold	5,651	–	–	0.01%	132
2021 Q1	$22K	Hold	5,651	–	–	0.01%	125
2020 Q4	$13K	Hold	5,651	–	–	﹤0.01%	155
2020 Q3	$10K	Hold	5,651	–	–	﹤0.01%	161
2020 Q2	$11K	Hold	5,651	–	–	﹤0.01%	143
2020 Q1	$8K	Hold	5,651	–	–	﹤0.01%	135
2019 Q4	$27K	Buy	+5,651	New	+$6.38K	0.01%	92

Other funds holding ONCY

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $218M AUM 37.48% 1-Year Est. Return

Cedar Mountain Advisors's ONCY Position: Q3 2026 in Review

Cedar Mountain Advisors held its Oncolytics Biotech (ONCY) position steady in Q3 2026 at 5,651 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Cedar Mountain Advisors first reported a position in ONCY in Q4 2019 and has held it in 28 quarters since. The position peaked at $27K in Q4 2019. 12 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

Cedar Mountain Advisors held 5,651 shares of Oncolytics Biotech worth $3.78K as of Q3 2026.
Cedar Mountain Advisors left its Oncolytics Biotech share count unchanged in Q3 2026.
Oncolytics Biotech made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #721 holding.
Cedar Mountain Advisors first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 28 quarters since.
Cedar Mountain Advisors's Oncolytics Biotech position peaked at $27K in Q4 2019.
12 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.